Common Contracts
3 similar Securities Issuance Agreement contracts by Intrexon Corp, Ziopharm Oncology Inc
EX-10.3 4 d219062dex103.htm EX-10.3 SECURITIES ISSUANCE AGREEMENTSecurities Issuance Agreement • May 5th, 2020 • New York
THIS SECURITIES ISSUANCE AGREEMENT (the “Agreement”), dated as of June 29, 2016, by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Issuer”), and Intrexon Corporation, a Virginia corporation (“Intrexon”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5. Intrexon and the Issuer may be referred to herein individually as a “Party” and collectively as the “Parties.”
SECURITIES ISSUANCE AGREEMENTSecurities Issuance Agreement • June 30th, 2016 • Intrexon Corp • Services-commercial physical & biological research • New York
THIS SECURITIES ISSUANCE AGREEMENT (the “Agreement”), dated as of June 29, 2016, by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Issuer”), and Intrexon Corporation, a Virginia corporation (“Intrexon”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5. Intrexon and the Issuer may be referred to herein individually as a “Party” and collectively as the “Parties.”
SECURITIES ISSUANCE AGREEMENTSecurities Issuance Agreement • June 30th, 2016 • Ziopharm Oncology Inc • Services-specialty outpatient facilities, nec • New York
THIS SECURITIES ISSUANCE AGREEMENT (the “Agreement”), dated as of June 29, 2016, by and among ZIOPHARM Oncology, Inc., a Delaware corporation (the “Issuer”), and Intrexon Corporation, a Virginia corporation (“Intrexon”). Capitalized terms used herein but not otherwise defined shall have the meanings given to them in Section 1.5. Intrexon and the Issuer may be referred to herein individually as a “Party” and collectively as the “Parties.”
